Several institutional investors increased or adjusted holdings in Synopsys Inc. (SNPS) in filings filed Feb. 3-5, 2026, even as the stock tumbled. Zurcher Kantonalbank bought 22,998 shares, raising its stake to about 171,310 shares (roughly $80.5 million). Penserra Capital added 32,080 shares to reach 72,662 shares (~$35.8 million), Portside Wealth purchased 4,692 shares (~$2.3 million) and Goldman Sachs’ Equal Weight U.S. Large Cap ETF added 2,685 shares. Conversely, Goldman Sachs ActiveBeta trimmed its holding by 7,316 shares. Institutional owners still control roughly 85% of SNPS. Shares fell as much as 7.22% on Feb. 3, hitting an intraday low near $417.55 before modest recovery; 52-week range is roughly $366–$652 and market capitalisation is near $80 billion. Synopsys reported Q3 results Dec. 10 (EPS $2.90; revenue $2.25 billion) and has issued FY2026 guidance; it also announced a Converge conference for March 11-12. Several law firms have opened investor inquiries, and Synopsys is scheduled to release Q1 fiscal 2026 results soon.

Aurora Cannabis Inc. reported fiscal third-quarter 2026 results on Feb. 4, 2026 for the period ended Dec. 31, 2025, highlighting a strategic pivot to higher-margin global medical cannabis. Total net revenue rose 7% year-over-year to C$94.2 million, with global medical revenue setting a record at C$76.2 million (up 12%). Consolidated adjusted gross margin improved 100 basis points to 62%; medical margins were 69%. Adjusted EBITDA was C$18.5 million and adjusted net income C$7.2 million. The company generated positive free cash flow of C$15.5 million and held C$154.4 million in cash and short-term investments, reporting no cannabis-business debt. Management said it will exit select lower-margin Canadian consumer markets, sell its controlling stake in plant-propagation business Bevo (to be treated as discontinued operations), and expects some one-time Q4 costs tied to those actions. Aurora also filed a prospectus supplement to establish an at-the-market (ATM) equity program to issue up to US$100 million of common shares to fund cultivation capacity, GMP expansion and potential M&A. Near-term headwinds include a 48% drop in consumer cannabis revenue and a sharp decline in plant propagation margins to 16% (including inventory write-offs).

International Flavors & Fragrances (IFF) shares climbed on Feb. 4, 2026, rising as much as 3.82% intraday to $73.88 and settling at $73.07 from a prior close of $70.38. Trading volume that day was about 556,514 shares, roughly 28.8% of average daily volume. The specialty ingredients group, listed on the NYSE with a market value near $18 billion, sits about 16% below its 52‑week high of $87.16 and 24% above its 52‑week low of $59.14. IFF is set to report fourth‑quarter and full‑year 2025 results after markets close on Feb. 11, with a conference call scheduled for Feb. 12 at 9:00 a.m. ET. Analysts project Q4 revenue of roughly $2.52 billion and EPS of about $0.84; consensus price targets cluster in the mid‑$80s. Recent 13F filings show sizable positioning moves: Zurich Cantonalbank and Davidson Investment Advisors exited holdings (339,212 and 122,984 shares sold, respectively), the New York State Common Retirement Fund reduced its stake (sold 75,969 shares, a 33.9% cut), while managers including TRAN Capital initiated or added material positions (325,326 shares).

Shares of Jabil Inc. (NYSE: JBL) fell on Feb. 4 after a mid-week pullback and a series of SEC filings showing mixed investor activity. Mid-day trading on Feb. 4 saw the stock gap down about 4.5% to $234.51 (intraday low $231.76) from a prior close of $245.64, with volume ~378,396 shares (~30.5% of avg). Recent filings show Jabil SVP Gary Schick sold 422 shares on Feb. 2; institutional repositioning included Zurcher Kantonalbank purchasing 114,598 shares (raising its stake to 144,775, ~$33.0m), Goldman Sachs’ equal-weight U.S. large-cap ETF buying 1,143 shares, and TD Waterhouse Canada trimming 857 shares. The company recently declared a $0.08 quarterly dividend (record date Feb. 17, payable Mar. 3), announced a $1 billion senior notes offering and board changes including Steve Raymund as chair. Jabil reported strong Q4 revenue ($8.3bn) and EPS ($2.85) in December; analysts’ average 12-month target sits near $264, implying upside from current levels. The company’s market cap is about $26bn with a P/E around the high 30s.

Capri Holdings (CPRI) reported fiscal Q3 results on Feb. 3-4, 2026 that modestly beat expectations and materially reshaped its balance sheet following the sale of Versace. Revenue for the quarter was $1.025 billion, down about 4% year-on-year, while non-GAAP EPS rose roughly 30% to $0.81, topping consensus by a few cents. Management said improved full-price sell-through and lower promotional activity boosted underlying margins, offset by higher tariff costs. Proceeds from the Versace sale (reported at about $1.4–1.5 billion) were used to cut net debt from roughly $1.6 billion to about $80 million. Capri provided FY26 guidance of $1.30–$1.40 EPS and roughly $3.45–$3.5 billion in revenue, and signaled priorities to reinvest in Michael Kors and Jimmy Choo, renovate stores and enhance digital capabilities, with a previously authorized $1 billion buyback program expected to begin in fiscal 2027. The earnings period coincided with wide analyst activity Feb. 3–4: Barclays raised its price target to $32 (overweight), Robert W. Baird upgraded to outperform ($26), while Goldman Sachs and Wells Fargo trimmed targets to $24 and $21 respectively; Telsey held at $23.

Galaxy Digital reported mixed Q4 and full-year 2025 results on Feb. 3-4, 2026, prompting a flurry of analyst revisions and share volatility. The company posted quarterly adjusted EPS of -$1.08, modestly beating a consensus -$1.24, while revenue fell to about $10.4 billion and trading volumes weakened. For the full year, Galaxy disclosed a GAAP net loss of $241 million but a record adjusted gross profit of $505 million and adjusted EBITDA of $34 million. Balance-sheet highlights include roughly $2.6 billion in cash and stablecoins, over $3 billion in equity capital and total assets near $11.3 billion. Galaxy’s data‑center business has 1.6 GW of approved power capacity, with initial data halls expected to begin generating cash by end-Q1 2026; full buildout timelines extend into 2028–29. Analysts reacted unevenly: Morgan Stanley kept an overweight rating but cut its target to $36, Goldman Sachs trimmed its target to $24 and maintained neutral, while BTIG, Canaccord and Citizens/JMP held higher targets ($50–$60). Shares slid across U.S. and Canadian listings following the results and guidance uncertainty.

Stanley Black & Decker on Feb. 4 reported mixed fourth-quarter and full‑year 2025 results, beating EPS expectations but showing revenue weakness and cautious 2026 guidance. Q4 net sales were $3.7 billion, down about 1% year‑on‑year with a 7% volume decline, while adjusted Q4 gross margin expanded to 33.3%. Full‑year net sales were $15.1 billion, adjusted gross margin 30.7% and adjusted EPS $4.67. The company generated strong cash flow (Q4 free cash flow $883 million; full‑year free cash flow roughly $688–700 million) and completed a global cost‑reduction program capturing $2.1 billion in run‑rate pretax savings. Management announced a definitive agreement to sell its aerospace fasteners (CAM) business for about $1.8 billion gross (net proceeds ~$1.5–1.6 billion) to materially reduce debt and target net leverage ≤2.5x. Stanley Black & Decker set FY‑2026 EPS guidance of $4.90–$5.70 (below Street) and expects top‑line volatility into Q1 due to tariff timing, volume deleverage and a transition to a licensing model for some outdoor products that will reduce reported revenue in 2026.

Payroll processor ADP reported on Feb. 4 that U.S. private-sector employers added just 22,000 jobs in January, roughly half the Dow Jones consensus of about 45,000 and below December’s revised gain of 37,000. Job growth was heavily concentrated in education and health services, which added an estimated 74,000 positions; by contrast professional and business services shed 57,000 jobs and manufacturing fell by 8,000. Medium-sized firms (50–499 employees) accounted for most net gains while large employers cut about 18,000 roles. ADP’s release also showed annual pay for job-stayers up 4.5% and pay for job-changers slowing to 6.4%. The report incorporated an annual benchmarking to QCEW through March 2025, lowering ADP’s historical job tallies. The Bureau of Labor Statistics has delayed the official January nonfarm payrolls release to Feb. 11 and moved the January CPI to Feb. 13 after a brief partial government shutdown, leaving markets to scrutinize private data for near-term signals.

Smurfit Westrock plc on Feb. 3–4 announced a quarterly dividend increase to $0.4523 per share (annualised $1.81) with an ex-dividend and record date of Feb. 17 and payment on March 18, 2026. The move lifted investor sentiment and shares rose roughly 6–8% in intraday trading on Feb. 4, trading in the low $40s (intraday highs reported around $43.7–$44.18). Analysts retain a broadly positive stance — MarketBeat and GuruFocus cite a consensus “moderate buy”/outperform view with an average target near $51.60 (GuruFocus average ~ $52.16) — even as some firms trimmed targets. Institutional ownership is high (about 83% reported) and filings show active position changes by funds including Federated Hermes and Zurcher Kantonalbank. The company is due to report Q4 2025 results and a medium-term investor update on Feb. 11, and summaries note a recent $1.3 billion senior note issuance that will affect its balance sheet. Key financial ratios cited include a current ratio ~1.48 and reported debt-to-equity around 0.72–0.77.

Keurig Dr Pepper (NASDAQ: KDP) said on Feb. 3-4, 2026 its board declared a regular quarterly cash dividend of $0.23 per share, payable April 10 to shareholders of record on March 27 (ex‑dividend date March 27). The payout equates to $0.92 annualized and a yield of roughly 3.2–3.3% based on recent prices. The announcements came amid trading around $28 and a market capitalisation near $38 billion, with a 52‑week range of $25.03–$36.12. At the same time, several institutional investors trimmed KDP positions: Zurcher Kantonalbank sold 51,347 shares (a 7.58% reduction), leaving 626,108 shares valued at about $17.5 million per its 13F filing, and Truist Financial disclosed it sold 94,295 shares, cutting its holding to 207,798 shares (a 31.2% decrease). Insider selling was also reported (VP Angela A. Stephens sold 10,000 shares in December). Market commentary around the filings also highlights upcoming fourth‑quarter results and ongoing strategic activity including a proposed JDE Peet’s transaction and potential share actions.

CME Group reported a landmark 2025 on Feb. 4, 2026, posting record annual revenue of $6.5 billion and its fifth consecutive year of record volume. Fourth-quarter revenue was about $1.65 billion with adjusted EPS of $2.77; full-year adjusted net income was roughly $4.1 billion. Average daily volume (ADV) reached an all-time annual average of 28.1 million contracts, with Q4 ADV about 27.4 million. Cryptocurrency trading surged — Q4 crypto ADV rose 92% to roughly 379,000 contracts — and CME plans to add new crypto futures on Feb. 9 and roll out 24/7 crypto trading next quarter. The SEC approved CME Securities Clearing in December, and management said a new clearing house launch and expanded CME‑FICC cross‑margining for clients are on track for 2026, aimed at generating about $80 billion in average daily margin efficiencies. Retail-focused initiatives (event contracts and micro products) showed early traction, with some 68 million event contracts traded in six weeks. Management flagged elevated volatility, fee and margin changes across metals and grains, legal uncertainty around prediction markets, and tokenized-collateral risks as operating challenges.

Zurn Elkay Water Solutions Corp (NYSE: ZWS) reported robust fourth-quarter and full-year 2025 results, driven by core sales growth and margin expansion. Q4 net sales were $407.2 million, up 10% core year‑over‑year; adjusted EBITDA for the quarter was $104.1 million (25.6% margin). For full-year 2025, net sales were $1.696 billion (+8% core), adjusted EBITDA was $442 million (26.1% margin) and record free cash flow was $317 million. The company returned capital with $160 million in share repurchases and $64 million in dividends, cutting net debt leverage to 0.4x. Management beat consensus EPS expectations (adjusted EPS $0.36 vs. $0.34) and set 2026 guidance targeting mid‑single‑digit core sales growth and roughly $335 million in free cash flow; first‑quarter core sales are expected to be up 7–8% with incremental adjusted EBITDA margins of about 35% (implying 25.5–26.0% reported margins). The release noted segment softness in some residential and commercial end markets and flagged risks from metal prices, tariffs and inflation. The stock traded to a 52‑week high on the results.

Devon Energy and Coterra Energy announced an all‑stock merger this week to create a combined shale producer with an enterprise value of about $58 billion, the companies said on Feb. 2–3, 2026. The deal — structured so Devon shareholders would own roughly 54% of the merged company — moves the enlarged group’s headquarters to Houston. Devon CEO Clay Gaspar will remain chief executive; Coterra CEO Tom Jorden will become non‑executive chairman. Management forecasts roughly $1 billion of annual synergies by end‑2027 from capital and operating efficiencies and corporate cost cuts. The announcement prompted broad analyst upward revisions: Barclays upgraded DVN to Overweight with a $50 target on Feb. 4, while Susquehanna, Scotiabank and Wolfe Research also raised targets in early February. Shares traded higher, hitting a 52‑week intraday high on Feb. 4 amid heavy call‑option activity (about 36,923 calls traded). Institutional filings show some portfolio moves around the deal — including Zurcher Kantonalbank’s exit of a 405,540‑share position — and shareholder‑rights firms have opened probes over deal fairness.

RenaissanceRe Holdings Ltd reported robust full-year 2025 results and strong fourth-quarter metrics, driven by underwriting, fee and investment income. The company posted $1.9 billion of operating income and $2.6 billion of net income available to common shareholders for 2025. Operating earnings per diluted share were $13.34 in Q4; annual net income per diluted share was $16.75. Tangible book value per share plus accumulated dividends rose about 30% in 2025 and book value per common share ended the year at $247.00. Underwriting income for Q4 was roughly $669 million; retained net investment income totaled about $1.2 billion for the year. Gross premiums written were reported near $11.7 billion with net premiums written around $9.9 billion. The reported combined ratio in the quarter was roughly 71% (adjusted ~70%); property catastrophe combined ratios were around 60%, while casualty and specialty reported an adjusted combined ratio above 100%. The company repurchased $650 million of shares in Q4 and returned about $1.6 billion to shareholders in 2025. Management warned of continued property CAT rate pressure and cited approximately $786 million net impact from large events, including California wildfires.

AvalonBay Communities Inc (NYSE: AVB) on Feb. 4 reported full-year 2025 results, issued initial 2026 outlook and raised its FY2026 earnings guidance. The REIT posted Q4 2025 EPS of $1.17 (down from $1.98 a year earlier) and reported Q4 FFO per share of $2.80 and Core FFO of $2.85. For full-year 2025, AvalonBay recorded EPS of $7.40 (vs. $7.60 in 2024), FFO of $11.40 and Core FFO of $11.24. Management set FY2026 EPS guidance at $11.00–$11.50 and Q1 2026 EPS at $2.73–$2.83. The company announced a 1.7% dividend increase and paid a quarterly dividend of $1.75 (annualized $7.00, ~3.9% yield). AvalonBay said it completed development of two wholly owned communities and continues a development pipeline of roughly 7,300 units; it also completed a $400 million senior notes offering. Shares rose about 2–3% on the news intraday, with institutional ownership remaining high at roughly 92.6%.

Amcor plc reported second-quarter results on Feb. 3–4, 2026 following its April 2025 combination with Berry Global. For the quarter ended Dec. 31, 2025 the Zurich‑based packaging group posted net sales of about $5.44 billion and adjusted EPS of $0.86, slightly above estimates while revenue missed consensus by roughly $70 million. Adjusted EBITDA rose to $826 million and adjusted EBIT to $603 million; free cash flow for the quarter was $289 million. Management said acquisition synergies totaled $55 million in Q2 and reaffirmed fiscal 2026 adjusted EPS guidance of $4.00–$4.15 and free cash flow of $1.8–$1.9 billion. The board declared a $0.65 quarterly dividend (record Feb. 25, payable Mar. 17). Company commentary flagged modest volume pressure — volumes about 1.5% below combined legacy levels — citing tariffs and weaker consumer spending in North America and Europe, while core categories such as pet care outperformed. U.S.-listed shares traded higher on the results and guidance.

Essex Property Trust Inc. (NYSE: ESS) on Feb. 4-5, 2026 reported fourth-quarter and full-year 2025 results and issued stronger-than-expected 2026 guidance. Q4 2025 core FFO per diluted share was $3.98 (up 1.5% year-on-year) and full-year core FFO was $15.94. GAAP net income per diluted share fell to $1.25 in Q4 from $4.00 a year earlier, reflecting prior-year gains. The REIT reported Q4 revenue of about $479.6 million and same-property revenue growth of 3.8% for the quarter. Essex set Q1 2026 EPS guidance at $3.890–4.010 and FY 2026 EPS guidance at $15.690–16.190, well above recent Street consensus figures. The company paid a quarterly dividend of $2.57 (annualized $10.28; ~4.1% yield) and ended 2025 with over $1.7 billion of immediately available liquidity. In the fourth quarter it issued $350 million of 10-year senior unsecured notes at a 4.875% coupon. Shares traded near $253 with a market capitalisation around $16.3 billion. Separately, Zurcher Kantonalbank trimmed its ESS holding by 8,788 shares to 59,898 in recent 13F filings.

Align Technology on Feb. 4 reported fourth-quarter and full-year 2025 results marked by record revenue, higher case volumes and improved margins. Q4 total revenue was $1.048 billion, up 5.3% year-over-year and 5.2% sequentially; clear aligner revenue was $838.1 million (up 5.5% YoY) with a record 676,900–677,000 clear aligner cases in Q4 (up 7.7% YoY). Full-year 2025 revenue totaled $4.0 billion (up 1%) with record clear aligner shipments of about 2.6 million cases (up 4.7%). Non-GAAP gross margin was 72.0% and non-GAAP operating margin about 26.1%, both above outlook. Align finished the year with $1.095 billion in cash, Q4 operating cash flow of $223.2 million and free cash flow of $187.3 million; it repurchased 2.9 million shares for $465.9 million in 2025 and has roughly $831.2 million remaining under a $1 billion buyback. Management highlighted international strength (EMEA, Latin America, APAC), growing teen/kid starts and DSO penetration (~25% of volume), while calling the macro backdrop “dynamic” and providing cautious 2026 guidance.

The Ensign Group Inc reported record fiscal 2025 results and on Feb. 4-5, 2026 issued 2026 guidance that topped street estimates. For the year ended Dec. 31, 2025 the company recorded GAAP diluted EPS of $5.84 and adjusted EPS of $6.57, with consolidated revenue of $5.06 billion and skilled services revenue of $4.84 billion. Fourth-quarter adjusted EPS was $1.82 on $1.36 billion of revenue (a slight miss versus consensus). Management set FY2026 guidance of $7.41–$7.61 in EPS and revenue around $5.77–$5.84 billion. Operational metrics improved: same-facility occupancy and transitioning occupancy hit record highs (83.8% and 84.9% respectively) and Medicare mix and skilled days rose. The company also highlighted growth in its Standard Bearer real-estate segment. Shares traded around $171–$173, valuing the company at about $10.03 billion, while insiders — including director Barry Smith — disclosed recent sales (Smith sold 700 shares on Feb. 2). Institutional ownership remains high.

Medtronic plc said on Feb. 3, 2026 it will exercise an option to acquire Israeli diagnostics firm CathWorks for up to $585 million, with additional milestone/earn-out payments possible. The deal—announced from Medtronic’s Galway, Ireland office—builds on a 2022 co-promotion agreement for CathWorks’ AI-driven FFRangio system, which derives fractional flow reserve (FFR) from routine angiograms to assess coronary physiology. Closing is subject to customary regulatory approvals, including review by the U.S. Federal Trade Commission, and is expected by the end of Medtronic’s fiscal 2026. Medtronic said the purchase should be immaterial to GAAP and adjusted EPS in fiscal 2027 and neutral-to-accretive thereafter. The announcement coincided with active institutional positioning in Medtronic stock: Cullen Capital trimmed its stake by about 1.1% (29,045 shares sold, per a Feb. 5 filing), Davidson Investment Advisors sold 1,752 shares (Feb. 4), while Zurich Cantonalbank added roughly 60,930 shares (Feb. 4). Analysts have flagged the deal as a strategic bolt-on that could expand recurring software and diagnostics revenue streams for Medtronic’s cardiovascular portfolio.

Multiple institutional investors disclosed position changes in Meta Platforms this week (filings Feb. 3–5, 2026), reflecting mixed but predominantly constructive positioning after Meta’s Jan. 28 Q4 beat and an aggressive ~30% Q1 revenue guide. Buyers included Saxon Interests (holding ~$5.66m), National Wealth Management (~$5.83m), Nicola Wealth (41,000 shares), AEGON Asset Management UK (added 13,739 shares to hold 465,288), Davidson Investment Advisors (+40,344 shares) and other funds. Several managers and pensions reduced or exited positions, notably Zurcher Kantonalbank (sold 1,084,925 shares) and AMF Tjanstepension (sold 217,672 shares), while Kornitzer and Sovran trimmed holdings. Insiders have also pared stakes in recent months (including Javier Olivan and Andrew Bosworth). Wall Street largely raised price targets after the results; MarketBeat consensus sits near $848.50. Shares pulled back in early February amid profit‑taking, but institutional ownership remains high (~79.9%) and the company’s market cap stays in the multi‑trillion dollar range. The filings highlight divergent tactical bets as markets weigh strong top‑line momentum against rising AI and infrastructure spending and regulatory risk.